These results highlight the potential of combining a GLP-1 agonist drug with IBT to achieve substantial weight loss
Plus Orlistat and Phentermine, the drugs DSS is seeking federal approval for, while cheaper, are much less effective at treating obesity and have more severe side effects, Toubman said
Lab work and baseline monitoring
PlexusDx's genetic panel examines GLP1R, GIPR, FTO, and MC4R variants that influence your individual peptide-hormone response and predicted tolerability of GLP-1 therapy
Research Evidence Hair loss research has produced some of the most reproducible GHK-Cu data, with multiple controlled studies demonstrating follicle enlargement and increased hair density in alopecia models
ALC has also been reported to exert cholinomimetic effects and to modulate the gamma-amino butyric acid (GABA) system